These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32833589)

  • 21. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population.
    Jumah NA; Edwards C; Balfour-Boehm J; Loewen K; Dooley J; Gerber Finn L; Kelly L
    BMJ Open; 2016 Oct; 6(10):e011774. PubMed ID: 27799240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
    Devlin LA; Davis JM
    Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.
    Krans EE; Patrick SW
    Obstet Gynecol; 2016 Jul; 128(1):4-10. PubMed ID: 27275812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal opioid use disorder and neonatal abstinence syndrome in northwest Ontario: a 7-year retrospective analysis.
    Dooley J; Ryan G; Gerber Finn L; Bollinger M; Matsumoto CL; Hopman WM; Kelly L
    Can J Rural Med; 2018; 23(2):39-44. PubMed ID: 29547380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.
    Saunders JB; Jarlenski MP; Levy R; Kozhimannil KB
    Womens Health Issues; 2018; 28(2):130-136. PubMed ID: 29183818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal abstinence syndrome.
    Jones HE; Kaltenbach K
    JAMA; 2012 Aug; 308(8):762-3; author reply 763. PubMed ID: 22910747
    [No Abstract]   [Full Text] [Related]  

  • 28. Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013.
    Warren MD; Miller AM; Traylor J; Bauer A; Patrick SW;
    MMWR Morb Mortal Wkly Rep; 2015 Feb; 64(5):125-8. PubMed ID: 25674995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: a rural and metropolitan comparison.
    Tetstall E; Liu AJ; An EI; Canalese J; Nanan R
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):279-84. PubMed ID: 19566560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.
    Faherty LJ; Kranz AM; Russell-Fritch J; Patrick SW; Cantor J; Stein BD
    JAMA Netw Open; 2019 Nov; 2(11):e1914078. PubMed ID: 31722022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemic of prescription opiate abuse and neonatal abstinence.
    Hayes MJ; Brown MS
    JAMA; 2012 May; 307(18):1974-5. PubMed ID: 22546607
    [No Abstract]   [Full Text] [Related]  

  • 32. Beyond the Treatment Box: Perspectives on the Federal Response to Opioid Use, Pregnancy, and Neonatal Abstinence Syndrome.
    Terplan M
    J Addict Med; 2017; 11(3):176-177. PubMed ID: 28406855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women, Infants, and Opioids.
    Lowe NK
    J Obstet Gynecol Neonatal Nurs; 2017; 46(5):657-659. PubMed ID: 28802558
    [No Abstract]   [Full Text] [Related]  

  • 34. Pregnancy and the Opioid Epidemic.
    Haycraft AL
    J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental Disorders and Medical Complications Among Infants with Subclinical Intrauterine Opioid Exposures.
    Hall ES; McAllister JM; Wexelblatt SL
    Popul Health Manag; 2019 Feb; 22(1):19-24. PubMed ID: 29893624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.
    Burns L; Mattick RP
    Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid Exposed Mothers and Infants in Delaware: Clinical and Legal Considerations.
    Savin MK; Paul DA
    Del Med J; 2016 Apr; 88(4):110-4. PubMed ID: 27263243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
    Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
    BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.